Brief: Xspray Increases Over-Allotment Issue
26/03/2026 14:59
March 26 (Reuters) - Xspray Pharma publ AB XSPRAY.ST: RIGHTS ISSUE NOW COVERED TO 110%, OVER-ALLOTMENT ISSUE INCREASED INCREASES OVER-ALLOTMENT ISSUE FROM SEK 20 MILLION TO SEK 30 MILLION Source text: ID:nMFN7pTYZS Further company coverage: XSPRAY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003